Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | STON1 |
| Upstream (Parents) |
|---|
| (<<) PALLD → STON1 |
| (<<) AEBP1 → STON1 |
| (<<) MYL9 → STON1 |
| (<<) FSTL1 → STON1 |
| Downstream (Children) |
|---|
| STON1 → GIPC2 (>>) |
| STON1 → C20orf103 (>>) |
| STON1 → ST8SIA1 (>>) |
| STON1 → PCDH7 (>>) |
| STON1 → KIRREL (>>) |
| STON1 → ACHE (>>) |
| STON1 → APBA2 (>>) |
| STON1 → TRPC1 (>>) |
| STON1 → PDZD2 (>>) |
| STON1 → VGLL3 (>>) |
| STON1 → OR7A10 (>>) |
| STON1 → LMOD1 (>>) |
| STON1 → SLC3A1 (>>) |
| STON1 → UGT1A6///UGT1A7///UGT1A8///UGT1A10 (>>) |
| STON1 → TRIM48 (>>) |
| STON1 → SOX15 (>>) |
| STON1 → PDZRN3 (>>) |
| STON1 → HOMER3 (>>) |
| STON1 → DUSP9 (>>) |
